Journal of Alzheimer's disease : JAD

publication venue for

Understanding Racial Disparities in Dementia Prevalence Among Veterans.. 100:1075-1082. 2024
Pimavanserin's Safety Profile: Insights from a Phase 3b Clinical Trial.. 99:1217-1220. 2024
The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.. 99:161-175. 2024
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation.. 98:593-600. 2024
"Landscape of Phase 2 Trials in Alzheimer's Disease": Perspective on Adaptive Trials.. 98:859-861. 2024
A Community-Based Study of Dementia in Mexican American and Non-Hispanic White Individuals.. 97:649-658. 2024
Aqueous and Plasma Levels of Phosphorylated Tau 181 in Individuals with Normal Cognition.. 100:239-245. 2024
Association of Plasma Amyloid-β and Dementia Among Black and White Older Adults.. 99:787-797. 2024
Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model.. 97:395-408. 2024
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging.. 97:1689-1702. 2024
Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.. 97:163-170. 2024
Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.. 99:321-332. 2024
Alzheimer's Disease Is a Multi-Organ Disorder: It May Already Be Preventable.. 91:1277-1281. 2023
Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.. 92:129-139. 2023
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas.. 95:509-521. 2023
Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.. 93:1381-1393. 2023
Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease.. 91:743-752. 2023
Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment.. 93:449-457. 2023
Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples.. 92:109-128. 2023
Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.. 92:1037-1049. 2023
Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease.. 92:457-466. 2023
Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes.. 96:197-214. 2023
Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification.. 95:1233-1252. 2023
Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.. 92:95-107. 2023
Gut Microbiota and Cognitive Function Among Women Living with HIV.. 95:1147-1161. 2023
Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease.. 96:813-825. 2023
Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.. 96:515-522. 2023
Involvement of Informal Caregivers in Preventing Falls in Older Adults with Cognitive Impairment: A Rapid Review.. 92:741-750. 2023
Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.. 93:495-507. 2023
Metabolic and Vascular Risk Factor Variability Over 25 Years Relates to Midlife Brain Volume and Cognition.. 91:627-635. 2023
Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.. 96:1505-1514. 2023
Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making.. 94:1607-1615. 2023
Multidimensional Sleep Health and Long-Term Cognitive Decline in Community-Dwelling Older Men.. 96:65-71. 2023
Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities.. 96:1339-1352. 2023
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease.. 91:977-987. 2023
Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals.. 96:1441-1451. 2023
Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.. 95:535-548. 2023
Prodromal Motoric Cognitive Risk Syndrome and Everyday Function.. 96:695-704. 2023
Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.. 92:341-348. 2023
Race Differences in the Association Between Sleep Medication Use and Risk of Dementia.. 91:1133-1139. 2023
Race and Ethnicity in Lewy Body Dementia: A Narrative Review.. 94:861-878. 2023
Racial/Ethnic Disparities in Misidentification of Dementia in Medicare Claims: Results from the Washington Heights-Inwood Columbia Aging Project.. 96:359-368. 2023
Retention of Study Partners in Longitudinal Studies of Alzheimer Disease.. 94:189-199. 2023
Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.. 95:615-624. 2023
Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.. 91:1073-1083. 2023
TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.. 91:1291-1301. 2023
The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.. 91:683-695. 2023
Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study.. 91:1141-1150. 2023
Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease.. 96:499-505. 2023
Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.. 95:93-117. 2023
"Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic.. 86:787-800. 2022
"I Didn't Sign Up for This": Perspectives from Persons Living with Dementia and Care Partners on Challenges, Supports, and Opportunities to Add Geriatric Neuropalliative Care to Dementia Specialty Care.. 90:1301-1320. 2022
A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks.. 85:1175-1187. 2022
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging.. 86:53-65. 2022
Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents.. 86:1149-1158. 2022
Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-β Burden.. 89:223-232. 2022
Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.. 86:1603-1609. 2022
Associations Between Midlife Functional Limitations and Self-Reported Health and Cognitive Status: Results from the 1998-2016 Health and Retirement Study.. 85:1621-1637. 2022
Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.. 87:1517-1526. 2022
Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.. 89:1103-1117. 2022
Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.. 90:405-417. 2022
Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.. 90:905-915. 2022
Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.. 87:1115-1130. 2022
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.. 89:193-207. 2022
Concordance Between Self-Reported Medical Diagnosis of Mild Cognitive Impairment/Dementia and Neurocognitive Function Among Middle-Aged and Older Hispanic/Latino Adults: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).. 88:45-55. 2022
Detecting Alzheimer's Disease Using Natural Language Processing of Referential Communication Task Transcripts.. 86:1385-1398. 2022
Diet Patterns, the Gut Microbiome, and Alzheimer's Disease.. 88:933-941. 2022
Difficulties with Activities of Daily Living and Receipt of Care Among Older Adults with Cognitive Impairment: Differences Between Those Living Alone and Those Living with Others.. 89:31-37. 2022
Dysphagia Profiles Among Inpatients with Dementia Referred for Swallow Evaluation.. 89:351-358. 2022
Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions.. 89:563-570. 2022
Increased Financial Altruism is Associated with Alzheimer's Disease Neurocognitive Profile in Older Adults.. 88:995-1005. 2022
Lack of Any Caregiving for Those with Dementia.. 86:531-535. 2022
Lessons from Detecting Cognitive Impairment Including Dementia (DetectCID) in Primary Care.. 86:655-665. 2022
Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease.. 87:1345-1365. 2022
Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments.. 87:761-769. 2022
Neuropathological and Clinical Correlates of Lewy Body Disease Survival by Race and Ethnicity in the National Alzheimer's Coordinating Center.. 89:1339-1349. 2022
Neuropsychiatric Inventory-Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer's Disease Predict More Rapid Cognitive Deterioration.. 86:1137-1147. 2022
Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L.. 90:823-840. 2022
Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study.. 86:1371-1383. 2022
Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease.. 88:721-729. 2022
Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.. 88:1615-1625. 2022
Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.. 86:271-281. 2022
Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.. 86:1935-1946. 2022
Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.. 86:1243-1254. 2022
Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease.. 85:905-924. 2022
Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.. 86:1471-1481. 2022
Sex Differences in Alzheimer's Disease Revealed by Free-Water Diffusion Tensor Imaging and Voxel-Based Morphometry.. 85:395-414. 2022
Sex Differences in Resilience and Resistance to Brain Pathology and Dysfunction Moderated by Cerebrovascular Response to Exercise and Genetic Risk for Alzheimer's Disease.. 90:535-542. 2022
Sex Modifies the Associations of APOEɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer's Disease.. 90:1571-1588. 2022
Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.. 86:1831-1848. 2022
Spoken Word Recognition in Listeners with Mild Dementia Symptoms.. 90:749-759. 2022
The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All.. 90:953-962. 2022
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer's Disease and Related Disorders.. 90:1817-1830. 2022
Use of Cognitive Testing, Questionnaires, and Plasma Biomarkers to Quantify Cognitive Impairment in an Aging Pet Dog Population.. 87:1367-1378. 2022
What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.. 87:1167-1179. 2022
Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging. 89:943-954. 2022
A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults.. 79:85-94. 2021
A Modified CAIDE Risk Score as a Screening Tool for Cognitive Impairment in Older Adults.. 82:1755-1768. 2021
APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.. 79:511-530. 2021
Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.. 83:1303-1312. 2021
Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.. 83:65-75. 2021
Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort.. 81:1131-1139. 2021
Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.. 84:1323-1335. 2021
Central Obesity, Cardiometabolic Risk, and Cognitive Change in the Study of Latinos - Investigation of Neurocognitive Aging.. 82:1203-1218. 2021
Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.. 80:1281-1297. 2021
Cigarette Smoking Status, Cigarette Exposure, and Duration of Abstinence Predicting Incident Dementia and Death: A Multistate Model Approach.. 80:1013-1023. 2021
Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.. 82:1667-1682. 2021
Clinical and Paraclinical Measures Associated with Outcome in Cerebral Amyloid Angiopathy with Related Inflammation.. 80:133-142. 2021
Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.. 80:1243-1256. 2021
Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results.. 79:559-572. 2021
Dementia Caregivers' Experiences Engaging Supportive Services While Residing in Under-Resourced Areas.. 84:169-177. 2021
Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline.. 83:1379-1389. 2021
Documentation of Dementia as a Cause of Death Among Mexican-American Decedents Diagnosed with Dementia.. 82:1727-1736. 2021
Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.. 82:1243-1257. 2021
Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies.. 82:647-659. 2021
Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice.. 83:1251-1268. 2021
Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis.. 82:1001-1013. 2021
Glucose-Dementia Association Is Consistent Over Blood Pressure/Antihypertensive Groups.. 80:79-90. 2021
Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort.. 79:1203-1211. 2021
Hispanic Perspectives on Parkinson's Disease Care and Research Participation.. 81:809-819. 2021
How Well Does Subjective Cognitive Decline Correspond to Objectively Measured Cognitive Decline? Assessment of 10-12 Year Change.. 83:291-304. 2021
Hypertension and Hypercholesterolemia Modify Dementia Risk in Relation to APOEɛ4 Status.. 81:1493-1504. 2021
Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept.. 79:1009-1014. 2021
Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients.. 84:227-237. 2021
Long-Term Exposure to Ambient Air Pollution and Cognitive Function Among Hispanic/Latino Adults in San Diego, California.. 79:1489-1496. 2021
Longitudinal Body Weight Change, Visit-To-Visit Body Weight Fluctuation, and Cognitive Decline Among Older Adults.. 84:777-786. 2021
Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation.. 80:1383-1387. 2021
Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer's Disease.. 83:539-544. 2021
Obesity and White Matter Neuroinflammation Related Edema in Alzheimer's Disease Dementia Biomarker Negative Cognitively Normal Individuals.. 79:1801-1811. 2021
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease.. 80:1051-1065. 2021
PET Imaging of Tau Pathology and Amyloid-β, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification.. 84:1497-1514. 2021
Passively-Measured Routine Home Computer Activity and Application Use Can Detect Mild Cognitive Impairment and Correlate with Important Cognitive Functions in Older Adulthood.. 81:1053-1064. 2021
Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.. 80:1553-1565. 2021
Plasma Biomarkers of Alzheimer's Disease in African Americans.. 79:323-334. 2021
Pre-Loss Grief in Caregivers of Older Adults with Dementia with Lewy Bodies.. 82:1847-1859. 2021
Pre-Statistical Considerations for Harmonization of Cognitive Instruments: Harmonization of ARIC, CARDIA, CHS, FHS, MESA, and NOMAS.. 83:1803-1813. 2021
Psychosocial Factors Associated with Cognitive Function Among Middle-Aged and Older Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos and its Sociocultural Ancillary Study.. 79:433-449. 2021
Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.. 81:355-366. 2021
Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.. 82:921-937. 2021
Self-Reported Dementia-Related Diagnosis Underestimates the Prevalence of Older Americans Living with Possible Dementia.. 82:373-380. 2021
Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.. 80:185-195. 2021
The Effect of Baseline Patient and Caregiver Mindfulness on Dementia Outcomes.. 79:1345-1367. 2021
The Free and Cued Selective Reminding Test Predicts Braak Stage.. 80:175-183. 2021
The Utility of Assessing Health-Related Quality of Life to Predict Cognitive Decline and Dementia.. 80:895-904. 2021
UDSNB 3.0 Neuropsychological Test Norms in Older Adults from a Diverse Community: Results from the Einstein Aging Study (EAS).. 83:1665-1678. 2021
Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.. 82:1809-1822. 2021
Assessing the Reliability of Reported Medical History in Older Adults.. 78:643-652. 2020
Association of Cardiovascular Risk Factors with Cerebral Perfusion in Whites and African Americans.. 75:649-660. 2020
Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy.. 73:1305-1311. 2020
CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease.. 73:1585-1595. 2020
Cardiovascular Risk and Cognitive Function in Middle-Aged and Older Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).. 73:103-116. 2020
Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis.. 76:207-215. 2020
Cognition and Daily Functioning: Results from the Hispanic Community Health Study/Study of Latinos (SOL) and Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).. 77:1267-1278. 2020
Dementia in People with a Turkish Migration Background: Experiences and Utilization of Healthcare Services.. 77:865-875. 2020
Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults.. 74:1045-1055. 2020
Ethical Issues Raised by the Introduction of Artificial Companions to Older Adults with Cognitive Impairment: A Call for Interdisciplinary Collaborations.. 76:445-455. 2020
Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment.. 77:165-174. 2020
Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia.. 78:371-386. 2020
Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.. 77:1469-1482. 2020
Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study.. 75:1437-1446. 2020
Factors Associated with Mortality Including Nursing Home Transitions: A Retrospective Analysis of 25,418 People Prescribed Anti-Dementia Drugs in Northern Ireland.. 73:1233-1242. 2020
Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease.. 77:745-752. 2020
Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus.. 78:3-12. 2020
Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption.. 75:471-482. 2020
Late-Life Physical and Cognitive Activities Independently Contribute to Brain and Cognitive Resilience.. 74:363-376. 2020
Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.. 74:965-974. 2020
Methods and Early Recruitment of a Community-Based Study of Cognitive Impairment Among Mexican Americans and Non-Hispanic Whites: The BASIC-Cognitive Study.. 73:185-196. 2020
Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease.. 74:1119-1129. 2020
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use.. 74:999-1009. 2020
Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.. 75:187-199. 2020
Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults.. 74:65-77. 2020
Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.. 76:579-589. 2020
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage.. 78:265-276. 2020
Pre-Diabetes, but not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle-Age.. 75:1241-1252. 2020
Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease.. 74:1085-1095. 2020
Screening for Lifetime History of Traumatic Brain Injury Among Older American and Irish Adults at Risk for Dementia: Development and Validation of a Web-Based Survey.. 74:699-711. 2020
Sex Differences in in vivo Alzheimer's Disease Neuropathology in Late Middle-Aged Hispanics.. 74:1243-1252. 2020
Stressful Life Events and Racial Disparities in Cognition Among Middle-Aged and Older Adults.. 73:671-682. 2020
The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.. 75:1319-1328. 2020
The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research.. 73:431-442. 2020
Waist Circumference and Domain-Specific Cognitive Function Among Non-Demented Japanese Older Adults Stratified by Sex: Results from the Takashima Cognition Study.. 73:887-896. 2020
A δ Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative.. 67:67-79. 2019
APOE ɛ4/ɛ4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load.. 72:1077-1087. 2019
Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.. 71:281-290. 2019
An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.. 68:1161-1170. 2019
Association of Cardiovascular and Alzheimer's Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans.. 72:919-929. 2019
Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease.. 69:953-961. 2019
Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.. 69:751-762. 2019
Complex Walking Tasks and Risk for Cognitive Decline in High Functioning Older Adults.. 71:S65-S73. 2019
Dementia Risk Elevates Brain Activity During Memory Retrieval: A Functional MRI Analysis of Middle Aged and Older Adults.. 70:1005-1023. 2019
Differences in Cataract Surgery Rates Based on Dementia Status.. 69:423-432. 2019
Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.. 68:657-668. 2019
Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.. 70:659-666. 2019
Frailty and Risk of Incident Motoric Cognitive Risk Syndrome.. 71:S85-S93. 2019
Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.. 69:145-156. 2019
Heterogeneity of Informant-Reported Functional Performance in Mild Cognitive Impairment: A Latent Profile Analysis of the Functional Activities Questionnaire.. 68:1611-1624. 2019
Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers.. 67:911-921. 2019
Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.. 69:1171-1182. 2019
Patient Perceptions of Antihypertensive Use as a Dementia Prevention Strategy: A Mixed-Method Analysis of a Web-Based Survey.. 68:523-529. 2019
Population-Based Approaches to Dementia Prevention.. 70:S15-S17. 2019
Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training.. 69:401-411. 2019
Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.. 67:757-768. 2019
Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia.. 67:257-263. 2019
Systematic Multi-Domain Alzheimer's Risk Reduction Trial (SMARRT): Study Protocol.. 70:S207-S220. 2019
Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.. 71:33-43. 2019
The Role of Care Navigators Working with People with Dementia and Their Caregivers.. 71:45-55. 2019
Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).. 67:685-705. 2019
δ Scores Identify Subsets of "Mild Cognitive Impairment" with Variable Conversion Risks.. 70:199-210. 2019
18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal.. 62:1691-1702. 2018
A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.. 61:1555-1573. 2018
A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.. 65:107-115. 2018
Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall.. 61:917-928. 2018
Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.. 62:385-397. 2018
Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies.. 66:1409-1424. 2018
Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.. 65:1417-1425. 2018
Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.. 61:79-89. 2018
Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.. 61:103-111. 2018
Correlates of Subjective Cognitive Decline in Lesbian, Gay, Bisexual, and Transgender Older Adults.. 64:91-102. 2018
DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease.. 66:927-934. 2018
Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.. 64:597-606. 2018
Default Mode Network Lateralization and Memory in Healthy Aging and Alzheimer's Disease.. 66:1223-1234. 2018
Delirium Severity Post-Surgery and its Relationship with Long-Term Cognitive Decline in a Cohort of Patients without Dementia.. 61:347-358. 2018
Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.. 64:1137-1148. 2018
Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.. 65:607-616. 2018
Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis.. 64:323-335. 2018
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.. 64:689-707. 2018
Memory Binding Test Predicts Incident Dementia: Results from the Einstein Aging Study.. 62:293-304. 2018
Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.. 61:295-307. 2018
Patterns of Neuropsychological Dysfunction and Cortical Volume Changes in Logopenic Aphasia.. 66:1015-1025. 2018
Plasma Antioxidant Status in Patients with Alzheimer's Disease and Cognitively Intact Elderly: A Meta-Analysis of Case-Control Studies.. 62:305-317. 2018
Psychometric Properties of Apathy Scales in Dementia: A Systematic Review.. 66:1065-1082. 2018
Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery-20181.. 66:1-10. 2018
Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.. 62:1713-1724. 2018
Risk Factors Associated with Cortical Thickness and White Matter Hyperintensities in Dementia Free Okinawan Elderly.. 63:365-372. 2018
Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.. 66:1587-1597. 2018
The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study.. 66:1041-1052. 2018
The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.. 61:1517-1529. 2018
Trajectories of Physiological Brain Aging and Related Factors in People Aged from 20 to over-80.. 65:1237-1246. 2018
Utility of Amyloid PET Scans in the Evaluation of Patients Presenting with Diverse Cognitive Complaints.. 66:1599-1608. 2018
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples.. 64:643-655. 2018
A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.. 56:1459-1468. 2017
A Novel Method for Direct Assessment of Everyday Competence Among Older Adults.. 57:1229-1238. 2017
Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.. 60:1451-1459. 2017
Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study.. 59:1307-1315. 2017
Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.. 56:351-359. 2017
Cognitive Status, Gray Matter Atrophy, and Lower Orthostatic Blood Pressure in Older Adults.. 57:1239-1250. 2017
Delayed Recall and Working Memory MMSE Domains Predict Delirium following Cardiac Surgery.. 59:1027-1035. 2017
Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study.. 59:975-985. 2017
Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.. 60:1183-1193. 2017
Interactive Effects of Dementia Severity and Comorbidities on Medicare Expenditures.. 57:305-315. 2017
Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.. 60:243-252. 2017
Memory Binding Test Predicts Incident Amnestic Mild Cognitive Impairment.. 58:951-952. 2017
Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.. 58:675-680. 2017
Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients.. 60:23-42. 2017
Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.. 56:743-761. 2017
Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.. 59:131-139. 2017
Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.. 56:1119-1126. 2017
Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data.. 55:1519-1528. 2017
The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia.. 59:251-263. 2017
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.. 56:929-938. 2017
The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort.. 59:1269-1282. 2017
The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.. 55:381-389. 2017
Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.. 56:733-742. 2017
Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.. 54:1395-1408. 2016
Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.. 54:1539-1550. 2016
Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.. 54:1259-1272. 2016
Anti-Viral Properties of Amyloid-β Peptides.. 54:859-878. 2016
A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults.. 54:793-9. 2016
A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.. 54:777-87. 2016
Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.. 54:373-81. 2016
Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly.. 53:1097-105. 2016
Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.. 53:547-56. 2016
The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.. 52:1299-310. 2016
Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups.. 52:1013-20. 2016
The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.. 52:539-59. 2016
Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.. 50:249-60. 2016
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.. 52:1055-64. 2016
Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.. 50:873-86. 2016
Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.. 53:921-32. 2016
Future Dementia Severity is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope.. 49:521-9. 2016
Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data.. 49:571-9. 2016
Impaired Autophagy in APOE4 Astrocytes.. 51:915-27. 2016
Less Daily Computer Use is Related to Smaller Hippocampal Volumes in Cognitively Intact Elderly.. 52:713-7. 2016
Microbes and Alzheimer's Disease.. 51:979-84. 2016
Mild Cognitive Impairment and Susceptibility to Scams in Old Age.. 49:845-51. 2016
Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.. 49:707-21. 2016
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.. 52:295-302. 2016
Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.. 50:1227-41. 2016
Vitamin D and Memory Decline: Two Population-Based Prospective Studies.. 50:1099-108. 2016
Welcome Back to Your Future: The Assessment of Dementia by the Latent Variable "δ".. 49:515-9. 2016
δ Scores are Exportable Across Cultural and Linguistic Boundaries.. 49:561-70. 2016
Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies.. 48 Suppl 1:S63-86. 2015
Adverse vascular risk is related to cognitive decline in older adults.. 44:1361-73. 2015
Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.. 47:1009-19. 2015
Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults.. 45:1197-206. 2015
Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia.. 48:453-62. 2015
Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.. 46:63-73. 2015
Ethnicity moderates dementia's biomarkers.. 43:275-87. 2015
Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders.. 43:121-32. 2015
Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers.. 46:525-33. 2015
NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.. 46:93-107. 2015
Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment.. 46:727-35. 2015
New Perspectives on Alzheimer's Disease and Nutrition.. 46:1111-27. 2015
Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodies.. 44:851-7. 2015
Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals.. 44:319-28. 2015
Serum leptin and risk of cognitive decline in elderly italians.. 44:1231-9. 2015
Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment.. 44:309-18. 2015
The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.. 47:421-32. 2015
Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.. 46:167-78. 2015
Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.. 46:423-9. 2015
A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients.. 38:661-8. 2014
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.. 38:111-20. 2014
Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies.. 42:1407-13. 2014
Arterial stiffness and cognitive function in the elderly.. 42 Suppl 4:S503-14. 2014
Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.. 42:275-89. 2014
Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.. 41:719-28. 2014
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.. 42:291-300. 2014
The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition.. 40:331-41. 2014
Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease.. 36:689-98. 2013
Coupled cognitive and functional change in Alzheimer's disease and the influence of depressive symptoms.. 34:851-60. 2013
Interaction of age and APOE genotype on cerebral blood flow at rest.. 34:921-35. 2013
Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center.. 33 Suppl 1:S447-55. 2013
5-HT₄ receptor stimulation leads to soluble AβPPα production through MMP-9 upregulation.. 32:437-45. 2012
Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease.. 31:335-41. 2012
Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease.. 31 Suppl 3:S155-67. 2012
Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease.. 30:53-61. 2012
The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial.. 32:147-56. 2012
Association of HSP70 and its co-chaperones with Alzheimer's disease.. 25:93-102. 2011
Gender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study.. 27:553-66. 2011
Independent component analysis-based classification of Alzheimer's disease MRI data.. 24:775-83. 2011
Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial.. 26:495-505. 2011
Can statins prevent or help treat Alzheimer's disease?. 20:925-33. 2010
Circulating angiogenic cells and Alzheimer's disease: contribution of the bone marrow to the pathogenesis of the disease.. 19:1241-3. 2010
Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma.. 21:769-73. 2010
Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease.. 22:483-92. 2010
Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.. 21:833-42. 2010
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.. 22:1305-11. 2010
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.. 17:681-97. 2009
Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology.. 18:509-13. 2009
The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited.. 17:807-15. 2009
Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind).. 12:229-40. 2007
The search for antecedent biomarkers of Alzheimer's disease.. 8:347-58. 2005
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation 2024
Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study 2023
Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer’s Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study 2022
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples 2018
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples 2018
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples 2018
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples 2018
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples 2018

Clin-STAR Database

Journal of Alzheimer's disease : JAD Journal

Overview

publication venue for

Identity

International Standard Serial Number (ISSN)